SEC Form D · filed December 5, 2022
Acer Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Tanya T. Hayden · Newton, MAExecJohn M. Dunn · Newton, MADirectorMichelle T. Griffin · Newton, MADirectorAdrian S. Quartel · Newton, MAExecChris Schelling · Cambridge, MAExec · DirectorHarry S. Palmin · Newton, MAExecMatthew T. Seibt · Newton, MAExecHarry S. Palmin · Newton, MAExecJohn M. Klopp · Newton, MAExecJason M. Amello · Newton, MADirectorAdrian S. Quartel · Newton, MAExecBernie S. Paul · Newton, MAExecBernie S. Paul · Newton, MAExecJohn M. Klopp · Newton, MAExecMatthew T. Seibt · Newton, MAExecJefferson E. Davis · Newton, MAExecJefferson E. Davis · Newton, MAExecJohn M. Dunn · Newton, MADirectorStephen T. Aselage · Newton, MADirectorMichelle T. Griffin · Newton, MADirectorJason M. Amello · Newton, MADirectorTanya T. Hayden · Newton, MAExecStephen T. Aselage · Newton, MADirectorDonald R. Joseph · Newton, MAExecDonald R. Joseph · Newton, MAExecChris Schelling · Cambridge, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗